10 Best Retirement Stocks to Buy According to Hedge Funds

8. Amgen Inc. (NASDAQ:AMGN)

Beta Value: 0.54

Dividend Yield: 3.14%

Number of Hedge Fund Holders: 72

Amgen Inc. (NASDAQ:AMGN) is a multinational biopharmaceutical company that specializes in human therapies for cancer, hematology, inflammation, bone health, and cardiovascular disorders. Repatha and EVENITY are two medications that are producing significant growth for the company.

On February 20, Bernstein analysts reduced the price target for Amgen (NASDAQ:AMGN) shares to $350 from $380, while keeping an Outperform rating. Amgen had a solid fourth quarter in 2024, with total revenues of $33.42 billion. This achievement was mostly due to the outstanding performance of the company’s key products, including Repatha, Evenity, and Tezspire. In addition, Bernstein analysts raised their projections for Repatha, emphasizing its consistent growth.